Bionano Genomics, Inc. 10-Q filing
Filed 2025-11-13 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001411690-25-000093
- Form type
- 10-Q
- CIK
- 0001411690
- Primary document
- https://www.sec.gov/Archives/edgar/data/1411690/000141169025000093/bngo-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bionano Genomics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $20.6M | - | - |
| Cost Of Revenue | $10.8M | - | - |
| Operating Income | $-24.8M | - | - |
| Net Income | $-18.5M | - | - |
| Eps Basic | -4.82 | - | - |
| Eps Diluted | -4.82 | - | - |
| Cash And Equivalents | $3.1M | - | - |
| Total Assets | $79.1M | - | - |
| Total Liabilities | $29.3M | - | - |
| Shareholders Equity | $49.8M | - | - |
| Operating Cash Flow | $-12.2M | - | - |